Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Crohn's disease

Not recruiting

Investigational

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Investigational

Hungary

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drug

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Ozanimod

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Hungary

Participants:0–17 years · 18–64 years · 65+ years
Substances:Etrasimod Arginine

Contact Research Centre

Major depression

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Aticaprant

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drug

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Find therapies in clinical trials near you – page 5

84 trials match your criteria

Crohn's disease

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Non-small cell lung cancer metastatic

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Non-small cell lung cancer metastatic

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Crohn's disease

Study on Risankizumab for Patients with Moderate to Severe Crohn's Disease

Breast cancer+1

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Colitis ulcerative

Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

Breast cancer

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

HER2 positive breast cancer

Study on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer

Colitis ulcerative

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

Major depression

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

Non-small cell lung cancer metastatic

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Breast cancer+3

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.